Showing 1 - 20 of 51 results
Managing Radioactive Waste
ANSTO has safely managed its radioactive waste for over 60 years. Waste is managed in accordance with national and international standards.
Privacy Policy
Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.
Innovative radioactive waste treatment technology forging ahead
International interest is building in Australia’s new multi-million-dollar radioactive waste processing facility at the Sydney campus of the Australian Nuclear Science and Technology Organisation (ANSTO).
Governance
ANSTO is a highly regulated organisation. Our governance system and processes provide critical guidance to effectively manage ANSTO’s activities. This section outlines the processes and systems that are in place to provide assurance to Government, our stakeholders and the community that we are working within our regulated and mandated requirements.
OPAL 2024 Shutdown
ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.
Plans to safely manage medical and research waste
ANSTO will make an application to the independent nuclear regulator, ARPANSA, to vary its license for its Interim Waste Store. The original operating license was approved in 2015, enabling the facility to hold what is called a TN-81 cask of intermediate-level radioactive waste that was safely repatriated from France in 2015.
Independent Report - Safety of Building 23
ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.
Bringing radiochemistry to life
Leveraging over half a century of knowledge in the safe management of radioactive waste
ANSTO's Chief Nuclear Officer shares insights on the safe management of Australia's nuclear waste.
Safeguarding the future of Australia's nuclear medicine
The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.
Experts share knowledge of nuclear medicine in live online forum
ANSTO recently hosted a public Ask Us Anything event on nuclear medicine, sharing information on how we safely manufacture and distribute nuclear medicine across Australia each week to hundreds of hospitals and clinics.
Teacher Professional Development Courses
ANSTO is an experienced provider of Teacher Professional Development for Australian and International teachers and our courses cover a wide range of topics. Hear from expert speakers, receive new education resources, and develop lessons for your own class.
Nuclear NextGen – ANSTO's Work Experience Intensive Days for 2026
Plans continue to repatriate medical and research radioactive waste
Australia’s nuclear agency ANSTO is continuing to lead planning efforts to repatriate what is called a TN-81 cask of intermediate-level radioactive from the United Kingdom in 2022.
ANSTO to help supply the world with nuclear medicine
Independent report into safety of Building 23 at ANSTO
The final report on the safety of Building 23 by the independent expert review team has been completed.
Repatriation of Australian waste from France
Clarity Pharmaceuticals raises $1.1 million
Community FAQs
Frequently asked questions about ANSTO for the community.